index	sentence1	sentence2	entailment
0	Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1) and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS- CoV-2 chimeric virus.	Measuring sars-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses	entailment
1	(A) The neutralizing effect of antibodies in the CHS was determined by a neutralization assay using the pseudotype viruses.	Measuring chs-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses	not_entailment
2	Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses 	Measuring aces-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses	not_entailment
3	Such chimeric GPs were examined for viral infectivity in K562-MGL/CD301 cells and MGL/CD301’s binding capacity to GPs.	Measuring gps-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses	not_entailment
4	Although virus-specific IgG play important roles in virus neutralization and prevention against future infection, limited information is available regarding the long term persistence of IgG after infection with SARS-like coronavirus.	Long-term persistence of igg antibodies in sars-cov infected healthcare workers	entailment
5	Long-term persistence of IgG antibodies in SARS-CoV infected healthcare workers.	 short-term persistence of igg antibodies in sars-cov infected healthcare workers	not_entailment
6	Long-term persistence of IgG antibodies in SARS-CoV infected healthcare workers.	Low-term persistence of igg antibodies in sars-cov infected healthcare workers	not_entailment
7	Long-term persistence of IgG antibodies in SARS-CoV infected healthcare workers.	Pre-term persistence of igg antibodies in sars-cov infected healthcare workers	not_entailment
8	also refer to the cytosolic portion of the coronaviral pore as a crown.	Coronavirus dons a new crown	entailment
9	The Coronavirus Outbreak › 	Coronavirus dons a new question	not_entailment
10	The Coronavirus Outbreak › 	Coronavirus dons a new term	not_entailment
11	Interestingly, the persistent immune reactivity in COVID-19 patients is predominantly targeted towards the Spike glycoprotein of the SARS-CoV-2.	Immune memory in mild covid-19 patients and unexposed donors from india reveals persistent t cell responses after sars-cov-2 infection	entailment
12	SARS-CoV-2 reactive T cells in healthy donors and patients with COVID-19.	Immune memory in mild covid-19 patients and unexposed donors from india reveals persistent t cell depletion after sars-cov-2 infection	not_entailment
13	Blood pressure: Probiotics may also cause modest reductions in blood pressure (57).	Simple probiotics might help inhibit covid-19 infection	entailment
14	These data lead to promising benefits of probiotics in reducing the risk of COVID-19.	Simple probiotics might help cause covid-19 infection	not_entailment
15	The export of the US-based AbbVies Kaletra / Aluvia, a combination lopinavir and ritonavir, the generic drug chloroquine phosphate and the generic drug hydroxychloroquine is being restricted to meet the needs of UK patients, the government said.	Uk bans parallel export and hoarding of lopinavir+ritonavir , chloroquine and hydroxychloroquine	entailment
16	The increase in fine particles is generally favored by air temperature inversions, characterized by fog situations, or by Saharan dust intrusions.	Air quality influences the pandemic - communiqués de presse	entailment
17	«In combination with a viral infection, these inflammatory factors can lead to a serious progression of the disease.	Virus quality influences the pandemic - communiqués de presse	not_entailment
18	“If the pandemic has taught us anything in the past eight months, it is how precious our health is,” Marcus said.	Health quality influences the pandemic - communiqués de presse	not_entailment
19	pandemic).	Global quality influences the pandemic - communiqués de presse	not_entailment
20	Our in-depth immune profiling reveals dyssynchrony of the innate and adaptive immune interaction in progressive COVID-19, which may contribute to delayed virus clearance and has implications for therapeutic intervention.	Single-cell omics reveals dyssynchrony of the innate and adaptive immune system in progressive covid-19	entailment
21	Single-Cell Omics Reveals Dyssynchrony of the Innate and Adaptive Immune System in Progressive COVID-19.	Single-brain omics reveals dyssynchrony of the innate and adaptive immune system in progressive covid-19	not_entailment
22	In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19.	Fenofibrate increases the amount of sulfatide which seems beneficial against covid-19	entailment
23	Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 Reference:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372998/ The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 The Probability of the 6-week Lockdown in Victoria (commencing 9 July 2020) Achieving Elimination of Community Transmission of SARS-CoV-2 	Fenofibrate reduces the amount of sulfatide which seems beneficial against covid-19	not_entailment
24	24.↵ K. Buschard, Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.	Fenofibrate reduced the amount of sulfatide which seems beneficial against covid-19	not_entailment
25	Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 Reference:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372998/ The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 The Probability of the 6-week Lockdown in Victoria (commencing 9 July 2020) Achieving Elimination of Community Transmission of SARS-CoV-2 	Fenofibrate decreased the amount of sulfatide which seems beneficial against covid-19	not_entailment
26	Here, we investigated the antiviral activity and associated mechanism of GNS561, a small basic lipophilic molecule inhibitor of late-stage autophagy, against SARS-CoV-2.	Gns561 exhibits potent in vitro antiviral activity against sars-cov-2 through autophagy inhibition	entailment
27	GNS561 Exhibits Potent In Vitro Antiviral Activity Against SARS-Cov-2 Through Autophagy Inhibition.	Gns561 exhibits no in vitro antiviral activity against sars-cov-2 through autophagy inhibition	not_entailment
28	Severe allergy-like reactions in at least eight people who received the COVID-19 vaccine produced by Pfizer and BioNTech over the past 2 weeks may be due to a compound in the packaging of the messenger RNA (mRNA) that forms the vaccines main ingredient, scientists say.	Suspicions grow that nanoparticles in pfizer 's covid-19 vaccine trigger rare allergic reactions.	entailment
29	Klimek L Novak N Hamelmann E Severe allergic reactions after COVID-19-Vaccination with the Pfizer/BioNTech Vaccine in Great Britain and USA.	Suspicions grow that nanoparticles in pfizer's covid-19 vaccine trigger systemic allergic reactions.	not_entailment
30	Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial c 	Berberine and obatoclax inhibit sars-cov-2 replication in primary human nasal epithelial cells in vitro.	entailment
31	Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial c 	Berberine and obatoclax induce sars-cov-2 replication in primary human nasal epithelial cells in vitro.	not_entailment
32	Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial c 	Berberine and obatoclax induced sars-cov-2 replication in primary human nasal epithelial cells in vitro.	not_entailment
33	Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial c 	Berberine and obatoclax are sars-cov-2 replication in primary human nasal epithelial cells in vitro.	not_entailment
34	Favilavir has been used by both Japan and China to treat severe cases of COVID-19, and the DCB team expects it to become a significant drug in treating the disease, according to the report.	Taiwan completes synthesis of potential covid-19 drug	entailment
35	(Elsevier Taiwan LLC) Severe acute respiratory syndrome coronavirus (SARS-CoV) proteins including ORF6 inhibit type I interferon (IFN) signaling.	Taiwan inhibits synthesis of potential covid-19 drug	not_entailment
36	Taiwan’s DCB Synthesizes Potential COVID-19 Treatment Favilavir As coronavirus cases continue to expand unstoppably around the globe, the focus is on discovering a vaccine.	Taiwan requires synthesis of potential covid-19 drug	not_entailment
37	In this cohort, significantly lower 25(OH)D levels ( p = 0.004) were found in PCR-positive for SARS-CoV-2 (median value 11.1 ng/mL) patients compared with negative patients (24.6 ng/mL); this was also confirmed by stratifying patients according to age >70 years.	25-hydroxyvitamin d concentrations are lower in patients with positive pcr for sars-cov-2	entailment
38	SARS-CoV-2 NAAT positivity rates and circulating 25(OH)D levels in the total population.	25-hydroxyvitamin d concentrations are elevated in patients with positive pcr for sars-cov-2	not_entailment
39	SARS-CoV-2 NAAT positivity rates and circulating 25(OH)D levels in the total population.	25-hydroxyvitamin d concentrations are increased in patients with positive pcr for sars-cov-2	not_entailment
40	25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2.	25-hydroxyvitamin d concentrations are higher in patients with positive pcr for sars-cov-2	not_entailment
41	Racial inequality may be as deadly as Covid-19 (replication package).	Us racial inequality may be as deadly as covid-19	entailment
42	Racial inequality may be as deadly as Covid-19 (replication package).	Us racial inequality may be as useful as covid-19	not_entailment
43	Racial inequality may be as deadly as Covid-19 (replication package).	Us racial inequality may be as effective as covid-19	not_entailment
44	racial inequality mortality COVID-19 	Us racial transmission may be as deadly as covid-19	not_entailment
45	One interesting observation was that it wasnt just individuals with verified COVID-19 who showed T-cell immunity but also many of their exposed asymptomatic family members, says Soo Aleman.	Immunity to covid-19 is probably higher than tests have shown	entailment
46	What’s more, not one of them had any symptoms of COVID-19.	Immunity to covid-19 is probably less than tests have shown	not_entailment
47	COVID-19: Public immunity ‘significantly higher’ than tests suggest This competition is now closed 	Immunity to covid-19 is probably lower than tests have shown	not_entailment
48	This was seen even in people who had mild or symptomless cases of Covid-19.	Immunity to covid-19 is probably smaller than tests have shown	not_entailment
49	A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds.	A novel in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyze neutralizing antibodies and antiviral compounds	entailment
50	A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds.	A standard in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyze neutralizing antibodies and antiviral compounds	not_entailment
51	A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds.	A conventional in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyze neutralizing antibodies and antiviral compounds	not_entailment
52	A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds.	A simple in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyze neutralizing antibodies and antiviral compounds	not_entailment
53	In a peer review of the antibody study published to Medium, former Stanford lecturer Balaji Srinivasan, who specializes in statistics and computational biology, argued the selection methods could have overstated the prevalence of the disease in the county.	Stanford professor balaji s. srinivasan 's peer review of the santa clara seroprevalence study indicates that its high reported positive rate results may be explained by the false positive rate of the test and/or by sample recruitment issues .	entailment
54	In a peer review of the antibody study published to Medium, former Stanford lecturer Balaji Srinivasan, who specializes in statistics and computational biology, argued the selection methods could have overstated the prevalence of the disease in the county.	Stanford professor balaji s. srinivasan's peer review of the santa clara seroprevalence study indicates that its high reported positive rate results cannot be explained by the false positive rate of the test and/or by sample recruitment issues.	not_entailment
55	The company has submitted a pharmacovigilance plan to FDA to monitor the safety of Pfizer-BioNTech COVID-19 Vaccine.	Fda takes key action in fight against covid-19 by issuing emergency use authorization for first covid-19 vaccine	entailment
56	FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine.	Sars takes key action in fight against covid-19 by issuing emergency use authorization for first covid-19 vaccine	not_entailment
57	The totality of the available data provides clear evidence that Pfizer-BioNTech COVID-19 Vaccine may be effective in preventing COVID-19.	China takes key action in fight against covid-19 by issuing emergency use authorization for first covid-19 vaccine	not_entailment
58	FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine.	Who takes key action in fight against covid-19 by issuing emergency use authorization for first covid-19 vaccine	not_entailment
59	About Us Team Platforms INSPECTR SHERLOCK Products Sherlock CRISPR SARS-CoV-2 Kit News Join Our Team 	Sherlock biosciences receives fda emergency use authorization for crispr sars-cov-2 rapid diagnostic	entailment
60	The Sherlock kit is the first CRISPR-based diagnostic test to receive EUA for the detection of SARS-CoV-2.	Sherlock biosciences receives no emergency use authorization for crispr sars-cov-2 rapid diagnostic	not_entailment
61	A-lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency.	Lipoic acid helps response in g6pd population	entailment
62	A-lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency.	Lipoic acid helps degradation in g6pd population	not_entailment
63	A-lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency.	Lipoic acid stress response in g6pd population	not_entailment
64	Accordingly, our in vitro data on SSPL suggest that administration of iota-carrageenan may be an effective and safe prophylaxis or treatment for SARS-CoV-2 infections.	Sars-cov-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan	entailment
65	SARS-CoV-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan.	Sars-cov-2 in-vitro neutralization assay blocked inhibition of virus entry by iota-carrageenan	not_entailment
66	Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.	Sars-cov-2 in-vitro neutralization assay reveals induction of virus entry by iota-carrageenan	not_entailment
67	Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.	Sars-cov-2 in-vitro neutralization assay reveals enhancement of virus entry by iota-carrageenan	not_entailment
68	The BMJ A covid-19 contact tracing pilot scheme in Sheffield has found that two thirds of people contacted did not fully cooperate, and many of those worked in health and care settings.	Two thirds of people contacted through tracing did not fully cooperate , pilot scheme finds	entailment
69	We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else, Soriot said.	Two thirds of people contacted through tracing did indeed fully cooperate, pilot scheme finds	not_entailment
70	Covid-19: Two thirds of people contacted through tracing did not fully cooperate, pilot scheme finds News 	Two thirds of people contacted through tracing did it fully cooperate, pilot scheme finds	not_entailment
71	Covid-19: Two thirds of people contacted through tracing did not fully cooperate, pilot scheme finds News 	Two thirds of people contacted through tracing did still fully cooperate, pilot scheme finds	not_entailment
72	Within this library, ciclesonide, an inhaled corticosteroid, suppressed human coronavirus replication in cultured cells, but did not suppress replication of respiratory syncytial virus or influenza virus.	The inhaled corticosteroid ciclesonide blocks coronavirus rna replication by targeting viral nsp15	entailment
73	The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15.	The inhaled corticosteroid ciclesonide support coronavirus rna replication by targeting viral nsp15	not_entailment
74	Cuomo warns US won't have enough hospital beds for coronavirus pandemic Published Mon, Mar 16 202011:27 AM EDTUpdated Mon, Mar 16 202012:18 PM EDT Berkeley Lovelace Jr.@BerkeleyJr ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email New York Gov.	The us doesnt have enough hospital beds for a bad coronavirus outbreak	entailment
75	Cloud area sparks fears of spreading virus … the area’s supply of hospital and ICU beds.	The usset have enough hospital beds for a bad coronavirus outbreak	not_entailment
76	Designating one hospital in the system to work specifically with coronavirus cases may allow them to go even higher.	The usert have enough hospital beds for a bad coronavirus outbreak	not_entailment
77	The approach that we used for designing potential peptide vaccine candidates takes a more personalized strategy, referred to as vaccinomics , which enables the selection of target viral proteins with low mutation rates, and the design of peptides tuned to the immune characteristics of the target populations, variable based on geographic location and ethnicity.	Oncogen researchers propose personalized vaccinomics strategy for the novel china coronavirus	entailment
78	According to them, the vaccine is developed through a technology used in personalized vaccination (oncogenic therapy) used in oncology.	Oncogen researchers propose personalized vaccinomics strategy for the traditional china coronavirus	not_entailment
79	Finally, comparison with two additional randomized clinical trials of vitamin D supplementation for COVID-19 in India and Brazil indicates that early intervention and rapid absorption may be crucial for the observed benefits of vitamin D. We conclude that the Córdoba study provides sufficient evidence to warrant immediate, well-designed pivotal clinical trials of early calcifediol administration in a broader cohort of inpatients and outpatients with COVID-19.	Mathematical analysis of córdoba calcifediol trial suggests strong role for vitamin d in reducing icu admissions of hospitalized covid-19 patients	entailment
80	Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients.	Mathematical analysis of córdoba calcifediol trial suggests strong role against vitamin d in reducing icu admissions of hospitalized covid-19 patients	not_entailment
81	New AI model detects asymptomatic Covid-19 infections through device-recorded coughs Vocal sentiments Prior to the pandemics onset, research groups already had been training algorithms on cellphone recordings of coughs to accurately diagnose conditions such as pneumonia and asthma.	Artificial intelligence model detects asymptomatic covid-19 infections through cellphone-recorded coughs	entailment
82	Not designed to diagnose Covid-19 However, despite the impressive findings, the team still has a long way to go in finding a way for the model to detect the differences between healthy coughs and unhealthy coughs in asymptomatic people.	Artificial intelligence model cannots asymptomatic covid-19 infections through cellphone-recorded coughs	not_entailment
83	Widespread antibody testing is also taking place in Colorados San Miguel County, where all residents will be provided with tests donated by United Biomedical executives who live in the county.	Stanford researchers test 3,200 people for covid-19 antibodies	entailment
84	Apr 10 2020 Justin Manalac, a senior clinical laboratory scientist at Stanford Health Care, prepares reagents for testing COVID-19 antibodies.	Stanford researchers test 3,6 people for covid-19 antibodies	not_entailment
85	(Photo: KATE SELIG/The Stanford Daily) By Kate Selig on April 4, 2020 Over 3,200 people in Santa Clara County were tested for COVID-19 antibodies on Friday and Saturday in an effort to determine the proportion of the population that either has or has recovered from coronavirus.	Stanford researchers test 3,5 people for covid-19 antibodies	not_entailment
86	(Photo: KATE SELIG/The Stanford Daily) By Kate Selig on April 4, 2020 Over 3,200 people in Santa Clara County were tested for COVID-19 antibodies on Friday and Saturday in an effort to determine the proportion of the population that either has or has recovered from coronavirus.	Stanford researchers test 3,3 people for covid-19 antibodies	not_entailment
87	The department said the state public health laboratory uncovered a flaw in one of the testing systems it uses to test for SARS-CoV-2, the virus that causes COVID-19, and 90 of 144 people tested between June 15 and July 17 received a false positive COVID test report.	State lab finds 90 positive covid-19 test results were false	entailment
88	The Department of Health said a total of 161 lab specimens from 144 individuals showed positive results for COVID-19 using the platform during the period of June 15-July 17.	State lab finds 90 positive covid-19 test results were+.	not_entailment
89	Our results help to quickly identify SARS-CoV-2 infections harboring mutations related to severe outcome.	Different mutations in sars-cov-2 associate with severe and mild outcome	entailment
90	Of note, destabilization mutations in nonstructural proteins were suggested to represent a potential mechanism differentiating SARS-CoV-2 from SARS-CoV.	Different mutations in sars-cov-2 associate against severe and mild outcome	not_entailment
91	Our results help to quickly identify SARS-CoV-2 infections harboring mutations related to severe outcome.	Both mutations in sars-cov-2 associate with severe and mild outcome	not_entailment
92	11, 2020-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced progress on late-stage development of mRNA-1273, the Companys mRNA vaccine candidate against COVID-19.	Moderna advances late-stage development of its vaccine against covid-19	entailment
93	Moderna, “Moderna Advances Late-Stage Development of its Vaccine Against COVID-19,” Press release, June 1, 2020, available at https://investors.modernatx.com/news-releases/news-release-details/moderna- advances-late-stage-development-its-vaccine-mrna-1273.	Moderna advances late-stage delivery of its vaccine against covid-19	not_entailment
94	One Sentence Summary We developed a mathematical model to explain why remdesivir has a greater antiviral effect on SARS CoV-2 in lung versus nasal passages in rhesus macaques.	Mathematical modeling explains differential sars cov-2 kinetics in lung and nasal passages in remdesivir treated rhesus macaques	entailment
95	Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2.	Phylogenetic modeling explains differential sars cov-2 kinetics in lung and nasal passages in remdesivir treated rhesus macaques	not_entailment
96	One Sentence Summary We developed a mathematical model to explain why remdesivir has a greater antiviral effect on SARS CoV-2 in lung versus nasal passages in rhesus macaques.	Mathematical depletion explains differential sars cov-2 kinetics in lung and nasal passages in remdesivir treated rhesus macaques	not_entailment
97	And so Singapore, Taiwan and Hong Kong might be more instructive examples.	Singapore , taiwan and hong kong have brought outbreaks under control	entailment
98	Singapore, Taiwan and Hong Kong have brought outbreaks under control — and without resorting to China’s draconian measures.	Singapore, taiwan and hong kong have no outbreaks under control	not_entailment
99	Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens 1.	Fda gives eua to saliva-based test kit	entailment
100	Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens 1.	Pcr gives eua to saliva-based test kit	not_entailment
101	While FDA has seen variable performance in tests using saliva, Yale School of Public Health submitted data with its EUA request from which the FDA determined that Yale’s test meets the criteria for emergency authorization when used to test saliva samples for SARS-CoV-2, the virus that causes COVID-19 infection.	Data gives eua to saliva-based test kit	not_entailment
102	OraSure Technologies has announced that its DNA Genotek subsidiary received EUA for the use of its OMNIgene® oral saliva collection device.	Table gives eua to saliva-based test kit	not_entailment
103	These antibodies were not associated with protection against SARS-CoV-2 infections or hospitalizations, but paradoxically these hCoV cross-reactive antibodies were boosted upon SARS-CoV-2 infection.	Seasonal human coronavirus antibodies are boosted upon sars-cov-2 infection but not associated with protection	entailment
104	Seasonal Human Coronavirus Antibodies Are Boosted upon SARS-CoV-2 Infection but Not Associated with Protection.	Seasonal human coronavirus antibodies are boosted upon sars-cov-2 infection but also associated with protection	not_entailment
105	Seasonal Human Coronavirus Antibodies Are Boosted upon SARS-CoV-2 Infection but Not Associated with Protection.	Seasonal human coronavirus antibodies are boosted upon sars-cov-2 infection but are associated with protection	not_entailment
106	The vaccine also appears to produce a strong response from special immune cells that help to mount a fast defence after infection with SARS-CoV-2.	Seasonal human coronavirus antibodies are boosted upon sars-cov-2 infection but strongly associated with protection	not_entailment
107	The results of the first nationwide representative screening will be released at the end of May.	Preliminary results of nationwide representative screening are out	entailment
108	The results of the first nationwide representative screening will be released at the end of May.	Preliminary results of nationwide representative screening are!	not_entailment
109	The results of the first nationwide representative screening will be released at the end of May.	Preliminary results of nationwide representative screening are?	not_entailment
110	The results of the first nationwide representative screening will be released at the end of May.	"Preliminary results of nationwide representative screening are""."	not_entailment
111	Self-administered COVID-19 coronavirus can be just as effective as physician- administered tests, according to a new study by UnitedHealth Group.	New self-administered coronavirus test found effective	entailment
112	But, then again, doctors say no test is ever 100% accurate.	No self-administered coronavirus test found effective	not_entailment
113	Electrostatic spraying is likely to improve coverage of disinfectant on surfaces and reduce wastage of disinfectant, but caution should be used in handling and applying the products.	Electrostatic spraying will prevent the spread of covid-19	entailment
114	Recently, there has been increased interest in the application of antimicrobial disinfectants on List N via electrostatic spray given the need to disinfect large indoor spaces to reduce the risk of exposure to the virus that causes COVID-19.	Electrostatic spraying will facilitate the spread of covid-19	not_entailment
115	Specific areas of focus include: Surface Areas: COVID-19 has raised awareness about the importance of high-touch surface cleanliness.	Electrostatic spraying will enhance the spread of covid-19	not_entailment
116	These large, indoor spaces have several high- touch surface areas that, if improperly cleaned, can induce the transmission of COVID-19.	Electrostatic spraying will promote the spread of covid-19	not_entailment
117	Science Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Zhang Q. et al.	Scientists trace severe covid-19 to faulty genes and autoimmune condition	entailment
118	We take a look at some recent studies that help explain how SARS-CoV-2, the virus that causes COVID-19, is so effective at attacking human cells.	Mice trace severe covid-19 to faulty genes and autoimmune condition	not_entailment
119	LED lights found to kill coronavirus efficiently, quickly, and cheaply 	Uv-emitting led lights found to kill coronavirus efficiently and cheaply.	entailment
120	We discovered that it is quite simple to kill the coronavirus using LED bulbs that radiate ultraviolet light.	Uv-emitting bat lights found to kill coronavirus efficiently and cheaply.	not_entailment
121	Conclusion: In our study, results show that the use of hydroxychloroquine for COVID-19 patients in mild to moderate cases in an outpatient setting, within the protocol recommendation and inclusion/exclusion criteria, is safe, highly tolerable, and with minimum side effects.	Hydroxychloroquine safety outcome within approved therapeutic protocol for covid-19 outpatients in saudi arabia	entailment
122	Share Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia Abdulrhman Mohana, Tarek Suliman, Nagla Mahmoud, Mustafa Hassanein, Amel Alfaifi, Eissa Alenazi, Nashwa Radwan, Nasser Alkhalifah, Ehab Elkady, Abdullah Almohaizeie, Fouad AboGazalah, Khaled AbdulKareem, Fahad AlGhofaili, Hani Jokhdar, Fahad Alrabiah medRxiv 2020.08.16.20175752; doi: https://doi.org/10.1101/2020.08.16.20175752 Share This Article: Copy Citation Tools Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia Abdulrhman Mohana, Tarek Suliman, Nagla Mahmoud, Mustafa Hassanein, Amel Alfaifi, Eissa Alenazi, Nashwa Radwan, Nasser Alkhalifah, Ehab Elkady, Abdullah Almohaizeie, Fouad AboGazalah, Khaled AbdulKareem, Fahad AlGhofaili, Hani Jokhdar, Fahad Alrabiah medRxiv 2020.08.16.20175752; doi: https://doi.org/10.1101/2020.08.16.20175752 	Hydroxychloroquine safety outcome within approved therapeutic protocol of covid-19 outpatients in saudi arabia	not_entailment
123	Share Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia Abdulrhman Mohana, Tarek Suliman, Nagla Mahmoud, Mustafa Hassanein, Amel Alfaifi, Eissa Alenazi, Nashwa Radwan, Nasser Alkhalifah, Ehab Elkady, Abdullah Almohaizeie, Fouad AboGazalah, Khaled AbdulKareem, Fahad AlGhofaili, Hani Jokhdar, Fahad Alrabiah medRxiv 2020.08.16.20175752; doi: https://doi.org/10.1101/2020.08.16.20175752 Share This Article: Copy Citation Tools Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia Abdulrhman Mohana, Tarek Suliman, Nagla Mahmoud, Mustafa Hassanein, Amel Alfaifi, Eissa Alenazi, Nashwa Radwan, Nasser Alkhalifah, Ehab Elkady, Abdullah Almohaizeie, Fouad AboGazalah, Khaled AbdulKareem, Fahad AlGhofaili, Hani Jokhdar, Fahad Alrabiah medRxiv 2020.08.16.20175752; doi: https://doi.org/10.1101/2020.08.16.20175752 	Hydroxychloroquine safety outcome within approved therapeutic protocol included covid-19 outpatients in saudi arabia	not_entailment
124	Share Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia Abdulrhman Mohana, Tarek Suliman, Nagla Mahmoud, Mustafa Hassanein, Amel Alfaifi, Eissa Alenazi, Nashwa Radwan, Nasser Alkhalifah, Ehab Elkady, Abdullah Almohaizeie, Fouad AboGazalah, Khaled AbdulKareem, Fahad AlGhofaili, Hani Jokhdar, Fahad Alrabiah medRxiv 2020.08.16.20175752; doi: https://doi.org/10.1101/2020.08.16.20175752 Share This Article: Copy Citation Tools Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia Abdulrhman Mohana, Tarek Suliman, Nagla Mahmoud, Mustafa Hassanein, Amel Alfaifi, Eissa Alenazi, Nashwa Radwan, Nasser Alkhalifah, Ehab Elkady, Abdullah Almohaizeie, Fouad AboGazalah, Khaled AbdulKareem, Fahad AlGhofaili, Hani Jokhdar, Fahad Alrabiah medRxiv 2020.08.16.20175752; doi: https://doi.org/10.1101/2020.08.16.20175752 	Hydroxychloroquine safety outcome within approved therapeutic protocol is covid-19 outpatients in saudi arabia	not_entailment
125	The spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia are divulging how they attach, fuse and gain entry to cells.	Covid-19 coronavirus spike holds infectivity details	entailment
126	Fisher, D. & Heymann, D. Q&A: the novel coronavirus outbreak causing COVID-19.	Covid-19 coronavirus genomes holds infectivity details	not_entailment
127	The whole time, we also knew that the Moderna vaccine was essentially safe.	We had the covid-19 vaccine the whole time	entailment
128	Can I choose which authorized COVID-19 vaccine I get?	We had the covid-19 vaccine the next time	not_entailment
129	​ How effective are the COVID-19 vaccines?	We had the covid-19 vaccine the following time	not_entailment
130	mRNA COVID-19 vaccines may be administered to persons who have received injectable dermal fillers who have no contraindications to vaccination (see 'contraindications' section below).	We had the covid-19 vaccine the second time	not_entailment
131	Here we present quantitative assay systems covering not only particle-cell and cell-cell fusion, but also demonstrating fusion-from-without (FFWO), the formation of syncytia induced by S-containing viral particles in absence of newly synthesized S protein.	Quantitative assays reveal cell fusion at minimal levels of sars-cov-2 spike protein and fusion-from-without	entailment
132	Share Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz bioRxiv 2020.10.15.340604; doi: https://doi.org/10.1101/2020.10.15.340604 Share This Article: Copy Citation Tools Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz bioRxiv 2020.10.15.340604; doi: https://doi.org/10.1101/2020.10.15.340604 	Quantitative assays reveal no fusion at minimal levels of sars-cov-2 spike protein and fusion-from-without	not_entailment
133	It is therefore very encouraging to see record- > high uptake rates this season, especially among the groups most vulnerable > to flu, who are also most at-risk from COVID-19.	Weekly national flu and covid-19 surveillance reports published	entailment
134	CDC is tracking the COVID-19 pandemic in a weekly publication called COVIDView.	Weekly national flu and covid-19 pandemic reports published	not_entailment
135	CDC is tracking the COVID-19 pandemic in a weekly publication called COVIDView.	Weekly national flu and covid-19 epidemic reports published	not_entailment
136	CDC is tracking the COVID-19 pandemic in a weekly publication called COVIDView.	Weekly national flu and covid-19 infection reports published	not_entailment
137	To avoid being recognized, coronaviruses express factors that interfere with host immune sensing pathways.	Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors	entailment
138	Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors.	Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host defense	not_entailment
139	Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs.	The spike glycoprotein of the new coronavirus 2019-ncov contains a furin-like cleavage site absent in cov of the same clade .	entailment
140	The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.	The spike glycoprotein of the new coronavirus a-ncov contains a furin-like cleavage site absent in cov of the same clade.	not_entailment
141	The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.	The spike glycoprotein of the new coronavirus s-ncov contains a furin-like cleavage site absent in cov of the same clade.	not_entailment
142	The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.	The spike glycoprotein of the new coronavirus e-ncov contains a furin-like cleavage site absent in cov of the same clade.	not_entailment
143	Its also launched a COVID-19 molecular test and the ID Now Rapid test, though UW scientists indicated this latest test is the most accurate so far.	Breakthrough covid-19 antibody test with nearly 100 % accuracy can help reopen economy	entailment
144	“Is that (having COVID-19 antibodies) enough to say, don't worry about going back into the public, you can't contract COVID-19, or if you contract it you can't spread it?	Breakthrough covid-19 antibody test with nearly 100 % accuracy cannot help reopen economy	not_entailment
145	Pharmacological PLP supplementation may therefore mitigate COVID-19 symptoms by alleviating both the immune suppression underlying viral spread and the pathological hypersecretion of inflammatory cytokines, as well as directly bolstering endothelial integrity and preventing hypercoagulability.	Pyridoxal 5'-phosphate to mitigate immune dysregulation and coagulopathy in covid-19	entailment
146	Desbarats J. Pyridoxal 5'-phosphate to mitigate immune dysregulation and coagulopathy in COVID-19.	Pyridoxal 5'- inability to mitigate immune dysregulation and coagulopathy in covid-19	not_entailment
147	Pyridoxal 5'-Phosphate to Mitigate Immune Dysregulation and Coagulopathy in COVID-19.	Pyridoxal 5'-phosphate to mitigate cardiac dysregulation and coagulopathy in covid-19	not_entailment
148	Pyridoxal 5'-Phosphate to Mitigate Immune Dysregulation and Coagulopathy in COVID-19.	Pyridoxal 5'-c to mitigate immune dysregulation and coagulopathy in covid-19	not_entailment
149	Patterns of IgG and IgM antibody response in COVID-19 patients.	Antibodies in infants born to mothers with covid-19 pneumonia	entailment
150	Antibodies in infants born to mothers with COVID-19 pneumonia.	Antibodies in women born to mothers with covid-19 pneumonia	not_entailment
151	The infants born to mothers with COVID-19 are carefully monitored for accompanying complication, and quarantine of infected mothers is warranted.	Mortality in infants born to mothers with covid-19 pneumonia	not_entailment
152	Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters PDF As the coronavirus disease 2019 (COVID-19) epidemic worsens, understanding the effectiveness of public messaging and large-scale social distancing interventions is critical.	Aggregated mobility data could help fight covid-19	entailment
153	Read the Science article: Aggregated mobility data could help fight COVID-19 Share this: Facebook Twitter LinkedIn Reddit 	Aggregated mobility data could not fight covid-19	not_entailment
154	Read the Science article: Aggregated mobility data could help fight COVID-19 Share this: Facebook Twitter LinkedIn Reddit 	Aggregated mobility data could help generate covid-19	not_entailment
155	Aggregated mobility data could help fight COVID-19.	Aggregated mobility data could help study covid-19	not_entailment
156	Using global line-list data on COVID-19 cases reported until 29th February 2020 and global gridded temperature data, and after adjusting for surveillance capacity and time since first imported case, higher average temperature was strongly associated with lower COVID-19 incidence for temperatures of 1°C and higher.	Preliminary evidence that higher temperatures are associated with lower incidence of covid-19 , for cases reported globally up to 29th february 2020	entailment
157	Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020. medRxiv.	Preliminary evidence that lower temperatures are associated with lower incidence of covid-19, for cases reported globally up to 29th february 2020	not_entailment
158	Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020. medRxiv.	Preliminary evidence that low temperatures are associated with lower incidence of covid-19, for cases reported globally up to 29th february 2020	not_entailment
159	So it looks like the vaccine has a very strong protective effect, and that's the first thing you'd want to know.	The fda weighs its first coronavirus vaccine	entailment
160	VACCINES Q & A: Have coronavirus vaccine questions?	The fda weighs its new coronavirus vaccine	not_entailment
161	Read more on COVID-19 coronavirus preventive vaccines Vaccine infectious disease Pandemic Preparedness U.S. FDA 	The fda weighs its sars coronavirus vaccine	not_entailment
162	Venous Thromboembolism in Hospitalized COVID-19 Patients.	High incidence of venous thromboembolic events in anticoagulated severe covid-19 patients	entailment
163	However, the exact incidence of venous thromboembolic event is unknown in anticoagulated, severe COVID-19 patients.	Low incidence of venous thromboembolic events in anticoagulated severe covid-19 patients	not_entailment
164	High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients.	Median incidence of venous thromboembolic events in anticoagulated severe covid-19 patients	not_entailment
165	High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients.	Average incidence of venous thromboembolic events in anticoagulated severe covid-19 patients	not_entailment
166	According to EPA, it would apply not only to studies behind EPA decisions about vehicle emissions, clean air standards, and clean water protections, but also EPAs own state-of-science reports, technology assessments, weight-of-evidence analyses, meta-analyses, risk assessments, toxicological profiles of substances, integrated assessment models, hazard determinations, exposure assessments, or health, ecological, or safety assessments. The EPA has not articulated a problem it wants to solve.	Epa proposes broad science restrictions in midst of coronavirus pandemic	entailment
167	Photo: EPA Posted in: Science and Democracy, Scientific Integrity Tags: COVID-19 and the Coronavirus Pandemic Support from UCS members make work like this possible.	Epa proposes broad science support in midst of coronavirus pandemic	not_entailment
168	The guidance posted on the CDC website states: “CDC recommends wearing cloth face coverings in public settings where other social distancing measures are difficult to maintain (e.g., grocery stores and pharmacies) especially in areas of significant community-based transmission.” AD The guidance was updated later Friday to highlight the word “especially” in bold.	Cdc proposes broad science restrictions in midst of coronavirus pandemic	not_entailment
169	In the midst of the coronavirus pandemic, the agency is recklessly giving the public just 60 days to comment on this sweeping proposal (the deadline is May 18) .	Who proposes broad science restrictions in midst of coronavirus pandemic	not_entailment
170	Story continues About the Moderna COVID-19 Vaccine The Moderna COVID-19 Vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center.	Moderna provides covid-19 vaccine supply update.	entailment
171	The Centers for Disease > Control and Prevention’s (CDC) Advisory Council on Immunization Practices > released their Interim Recommendation for Allocating Initial Supplies of > COVID-19 Vaccine, recommending healthcare personnel (including dentists, > dental hygienists, and dental assistants) and long-term care facility > residents be the first to receive the vaccine as part of Phase 1-A.	Cdca provides covid-19 vaccine supply update.	not_entailment
172	Can I receive the COVID-19 vaccine at MultiCare?	Wa provides covid-19 vaccine supply update.	not_entailment
173	Engineered ACE2 receptor traps present key advantages in treating SARS-CoV-2 infections.	Engineered ace2 receptor traps potently neutralize sars-cov-2	entailment
174	, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.	Engineered ace2 receptor cannot potently neutralize sars-cov-2	not_entailment
175	Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.	Recombinant ace2 receptor traps potently neutralize sars-cov-2	not_entailment
176	Masks worn by patients may not offer as great a degree of protection against aerosol transmission.	Professional and home-made face masks reduce exposure to respiratory infections among the general population	entailment
177	Here we report an analysis of 20 whole SARS-CoV 2 genomes from a single relatively small and geographically constrained outbreak in Weifang, People's Republic of China.	Genomic epidemiology of a densely sampled covid19 outbreak in china	entailment
178	Genomic epidemiology of a densely sampled COVID19 outbreak in China.	Genomic epidemiology of a randomly sampled covid19 outbreak in china	not_entailment
179	Timeline of exposure and connections between cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among persons in Heilongjiang Province, China.	Large sars-cov-2 outbreak caused by asymptomatic traveler , china	entailment
180	Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.	One sars-cov-2 outbreak caused by asymptomatic traveler, china	not_entailment
181	It will compare two or three therapies backed by scientific evidence, including an HIV-drug combination (lopinavir and ritonavir) and an experimental antiviral called remdesivir.	More than 80 clinical trials launch to test coronavirus treatments	entailment
182	More than 80 clinical trials have been launched to test coronavirus treatment, including some drug repurposing or repositioning for COVID-19.	 less than 80 clinical trials launch to test coronavirus treatments	not_entailment
183	Early laboratory studies suggested that the drug, as well as a similar medicine named chloroquine, might interfere with replication of the coronavirus, but trials in humans have been inconclusive so far.	 fewer than 80 clinical trials launch to test coronavirus treatments	not_entailment
184	More than 80 clinical trials launch to test coronavirus treatments.	 younger than 80 clinical trials launch to test coronavirus treatments	not_entailment
185	Here, we report that a ferritin nanoparticle based SARS-CoV-2 RBD vaccine induced in mice an efficient antibody response which lasts for at least 7 months post immunization.	Ferritin nanoparticle based sars-cov-2 rbd vaccine induces persistent antibody response and long-term memory in mice.	entailment
186	Ferritin nanoparticle based SARS-CoV-2 RBD vaccine induces persistent antibody response an 	Ferritin nanoparticle based sars-cov-2 rbd vaccine induces persistent antibody response and long-term memory in humans.	not_entailment
187	In summary, data presented here demonstrated that a ferritin-NP-based preS1 vaccine manifests an efficient antibody response that is both preventive and therapeutic in a mouse HBV model via coordinately dual-targeting SIGNR1+ resident DCs and macrophages in the LNs.	Ferritin nanoparticle based sars-cov-2 rbd vaccine induces persistent antibody response and long-term memory in rabbits.	not_entailment
188	Ferritin nanoparticle based SARS-CoV-2 RBD vaccine induces persistent antibody response and long-term memory in mice Wenjun Wang; Baoying Huang; Yanping Zhu; Wenjie Tan; Mingzhao Zhu.	Ferritin nanoparticle based sars-cov-2 rbd vaccine cans persistent antibody response and long-term memory in mice.	not_entailment
189	Category: Research Tags: COVID-19 hydroxychloroquine clinical trial 	Hydroxychloroquine fails to prevent covid-19	entailment
190	Additionally, no difference was seen in non- COVID-19 mortality associated with hydroxychloroquine use.	Hydroxychloroquine remains to prevent covid-19	not_entailment
191	Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19.	Hydroxychloroquine appears to prevent covid-19	not_entailment
192	Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19.	Hydroxychloroquine is to prevent covid-19	not_entailment
193	Transmission of SARS-CoV-2 in Domestic Cats.[letter].	Transmission of sars-cov-2 in domestic cats imposes a narrow bottleneck.	entailment
194	Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck 	Transmission of sars-cov-2 in domestic cats imposes a global bottleneck.	not_entailment
195	Study: Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck.	Transmission of sars-cov-2 in domestic cats imposes a major bottleneck.	not_entailment
196	Transmission of SARS-CoV-2 in Domestic Cats.[letter].	Transmission of sars-cov-2 in domestic cats imposes a common bottleneck.	not_entailment
197	SACRAMENTO, Calif. -- UPDATE: Pause lifted on batch of Moderna COVID-19 vaccines, health officials say Advertisement ORIGINAL STORY: California's top epidemiologist has asked providers to stop giving shots from a batch of the Moderna COVID-19 vaccine as the state investigates reports of allergic reactions.	California state epidemiologist statement recommending providers pause administration of single lot of moderna covid-19 vaccine.	entailment
198	Health officials in California have told healthcare providers they can resume using a single lot of the Moderna COVID-19 vaccine.	California state epidemiologist statement recommending providers include administration of single lot of moderna covid-19 vaccine.	not_entailment
199	Here, we provide evidences on the efficacy of baricitinib, a JAK1/JAK2 inhibitor, in correcting the immune abnormalities observed in patients hospitalized with COVID-19.	Baricitinib restrains the immune dysregulation in covid-19 patients	entailment
200	N	Uncitinib restrains the immune dysregulation in covid-19 patients	not_entailment
201	N	Excitinib restrains the immune dysregulation in covid-19 patients	not_entailment
202	Published on pre-publication server arXiv, the researchers found that the IHME model substantially underestimates the uncertainty associated with COVID-19 deaths.	Us covid-19 deaths poorly predicted by ihme model	entailment
203	Published on pre-publication server arXiv, the researchers found that the IHME model substantially underestimates the uncertainty associated with COVID-19 deaths.	Us covid-19 deaths as predicted by ihme model	not_entailment
204	Published on pre-publication server arXiv, the researchers found that the IHME model substantially underestimates the uncertainty associated with COVID-19 deaths.	Us covid-19 deaths previously predicted by ihme model	not_entailment
205	IHME COVID-19 Forecasting Team.	Us covid-19 deaths were predicted by ihme model	not_entailment
206	Its not unusual to count things in different ways as the epidemic evolves, said Sylvie Briand, WHO director of the infectious hazards management department.	China 's changing coronavirus case count is not unusual in an outbreak , health official says	entailment
207	Confusion over how China is counting cases of infections is making it harder to know how coronavirus is spreading, even as China is officially reporting that the numbers of new cases reported in recent days have fallen sharply.	China's changing coronavirus case count is not available in an outbreak, health official says	not_entailment
208	Confusion over how China is counting cases of infections is making it harder to know how coronavirus is spreading, even as China is officially reporting that the numbers of new cases reported in recent days have fallen sharply.	China's changing coronavirus case count is very unusual in an outbreak, health official says	not_entailment
209	Confusion over how China is counting cases of infections is making it harder to know how coronavirus is spreading, even as China is officially reporting that the numbers of new cases reported in recent days have fallen sharply.	China's changing coronavirus case count is particularly unusual in an outbreak, health official says	not_entailment
210	Antibody testing is done by means of blood drawn through a finger prick and detects whether your blood has antibodies that are present when the body is responding to an infection, like COVID-19.	Results released for antibody and covid-19 testing of boston residents	entailment
211	There are 2 types of COVID-19 testing: Virus Testing and Antibody Testing.	Results released for antibody and covid-19 production of boston residents	not_entailment
212	WHO currently recommends that people should wear face masks if they have respiratory symptoms or if they are caring for somebody with symptoms.	Vulnerable populations , such as older adults and those with underlying medical conditions , should wear face masks if available .	entailment
213	Note: If you choose to require face coverings, do not require them for very young children or people who cannot wear a face covering for a medical or disability-related reason.	Vulnerable populations, such as older adults and those with underlying medical conditions, not wear face masks if available.	not_entailment
214	(Express Photo: Amit Chakravarty) A new study suggests that the differing immune system responses of Covid-19 patients can help predict who will experience moderate and severe consequences of disease.	The differing immune system responses of patients with covid-19 can help predict who will experience moderate and severe consequences of disease , according to a new study	entailment
215	Uncertainty is hampering doctors’ ability to choose treatments Numerous studies have suggested that the immune system contributes to the organ damage seen in some severe cases of COVID-19.	The differing immune system responses of patients with covid-19 cannot help predict who will experience moderate and severe consequences of disease, according to a new study	not_entailment
216	Tables show the immune parameters that have been reported to differ between mild and severe COVID-19.	The differing immune system responses of patients with covid-19 can help predict who will experience moderate and severe consequences of disease, according to a previous study	not_entailment
217	Pic: Facebook/Me and my MND image/svg+xml Why you can trust Sky News A wonderfully kind father-of-two who was fighting motor neurone disease (MND) has become the youngest person to die after testing positive for coronavirus in the UK.	Father with motor neurone disease dies from coronavirus in uk	entailment
218	Pic: Facebook/Me and my MND image/svg+xml Why you can trust Sky News A wonderfully kind father-of-two who was fighting motor neurone disease (MND) has become the youngest person to die after testing positive for coronavirus in the UK.	Father with motor neurone disease originated from coronavirus in uk	not_entailment
219	Kennedy’s disease (spinal and bulbar muscular atrophy, bulbo-spinal muscular atrophy, X-linked spinal and bulbar muscular atrophy) is an X-linked recessive disease that affects men.	Father with motor neurone disease differs from coronavirus in uk	not_entailment
220	Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing 1.	Yale 's rapid covid-19 saliva test receives fda emergency use authorization	entailment
221	While FDA has seen variable performance in tests using saliva, Yale School of Public Health submitted data with its EUA request from which the FDA determined that Yale’s test meets the criteria for emergency authorization when used to test saliva samples for SARS-CoV-2, the virus that causes COVID-19 infection.	Yale's rapid covid-19 saliva test without fda emergency use authorization	not_entailment
222	Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase.	The antiviral compound remdesivir potently inhibits rna-dependent rna polymerase from middle east respiratory syndrome coronavirus	entailment
223	The Antiviral Compound Remdesivir Potently Inhibits RNA-Dependent RNA Polymerase from Middle East Respiratory Syndrome Coronavirus.	The antiviral compound remdesivir potently binds rna-dependent rna polymerase from middle east respiratory syndrome coronavirus	not_entailment
224	Professor Andy Pollard, Director of the Oxford Vaccine Group and Chief Investigator of the Oxford Vaccine Trial, said: Were excited to see our colleagues in Kenya today joining those around the world in helping us to evaluate the ChAdOx1 nCov-2019 Oxford coronavirus vaccine, as it is important to evaluate the vaccine in as many different populations as possible. Kenya joins a number of countries including the United Kingdom, South Africa and Brazil who are running trials to evaluate the ChAdOx1 nCoV-19 vaccine, with over 20,000 volunteers now taking part in trials across these countries.	Trials of oxford coronavirus vaccine begin in kenya	entailment
225	Trials of Oxford coronavirus vaccine begin in Kenya 	Lack of oxford coronavirus vaccine begin in kenya	not_entailment
226	Getty Images Email icon Facebook icon Twitter icon Linkedin icon Flipboard icon Print icon Resize icon A coronavirus vaccine being developed by Oxford University has begun human trials with the first two patients being injected with the potential vaccine.	Trials of oxford coronavirus vaccine begin in great	not_entailment
227	Model predictions fail because the observed infection rates are beyond modeling: any model that uses fixed rates or uses memory or averages of past rates cannot reproduce the data on active infections.	Pandemic infection rates are deterministic but can not be modeled	entailment
228	Pandemic Infection Rates Are Deterministic but Cannot Be Modeled 	Pandemic infection rates are deterministic but can then be modeled	not_entailment
229	Pandemic Infection Rates Are Deterministic but Cannot Be Modeled 	Pandemic infection rates are deterministic but can therefore be modeled	not_entailment
230	Pandemic Infection Rates Are Deterministic but Cannot Be Modeled 	Pandemic infection rates are deterministic but can also be modeled	not_entailment
231	The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world.	New coronavirus variant is identified in uk.	entailment
232	The BBC is not responsible for the content of external sites.	No coronavirus variant is identified in uk.	not_entailment
233	The coronavirus has mutated and May52020 COVID19 KEY POINTS: The coronavirus that emerged in Wuhan, China, has mutated and the new, dominant strain spreading across the U.S. appears to be even more contagious, according to a new study.	The coronavirus has mutated and appears to be more contagious now , new study finds	entailment
234	Patients with that strain of coronavirus carried more virus particles than other people, meaning they were probably more infectious, the study found.	The coronavirus has mutated and appears to be more contagious before, new study finds	not_entailment
235	Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.	Two known therapies could be useful as adjuvant therapy in critical patients infected by covid-19	entailment
236	Two known therapies could be useful as adjuvant therapy in critical care patients infected by COVID-19 in press Rev Esp Anestsiol Reanim.	Many known therapies could be useful as adjuvant therapy in critical patients infected by covid-19	not_entailment
237	/ Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.	Several known therapies could be useful as adjuvant therapy in critical patients infected by covid-19	not_entailment
238	/ Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.	All known therapies could be useful as adjuvant therapy in critical patients infected by covid-19	not_entailment
239	In this Communication, we first analyzed two recent studies that concluded that snakes are the intermediate hosts of 2019-nCoV and that the 2019-nCoV spike protein insertions share a unique similarity to HIV-1.	Protein structure and sequence reanalysis of 2019-ncov genome refutes snakes as its intermediate host and the unique similarity between its spike protein insertions and hiv-1	entailment
240	This article is based on a previously available preprint: Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1.	Protein structure and sequence reanalysis of 2019-ncov genome refutes bats as its intermediate host and the unique similarity between its spike protein insertions and hiv-1	not_entailment
241	Dr June Raine, MHRAs CEO, said: > We have told those conducting clinical trials using hydroxychloroquine to > treat or prevent COVID-19 to suspend recruitment into their trials.	Mhra suspends recruitment to covid-19 hydroxychloroquine trials	entailment
242	See our guidance on chloroquine/hydroxychloroquine and COVID-19.	Mhra acts recruitment to covid-19 hydroxychloroquine trials	not_entailment
243	A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.	Mhra 1990s recruitment to covid-19 hydroxychloroquine trials	not_entailment
244	All hydroxychloroquine trials in COVID-19 remain under close review, it added.	Mhra 1980s recruitment to covid-19 hydroxychloroquine trials	not_entailment
245	Our study provides new insights into a potential role for TRPM5-expressing cells in viral infection of the olfactory epithelium.	Transcriptional profiling reveals trpm5-expressing cells involved in viral infection in the olfactory epithelium	entailment
246	Coverage of TRPM5 transcript by RNAseq in the different cell groups sorted from the olfactory epithelium a.	Transcriptional profiling reveals trpm5-deficient cells involved in viral infection in the olfactory epithelium	not_entailment
247	Conclusion Our study provides new insights into a potential role for TRPM5-expressing microvillous cells in viral infection of the olfactory epithelium.	Transcriptional profiling reveals trpm5-depleted cells involved in viral infection in the olfactory epithelium	not_entailment
248	Conclusion: Our study provides new insights into a potential role for TRPM5-expressing microvillous cells in viral infection of the olfactory epithelium.	Immunal profiling reveals trpm5-expressing cells involved in viral infection in the olfactory epithelium	not_entailment
249	Herein, we showed that the protease inhibitor aprotinin (but not the protease inhibitor SERPINA1/alpha-1 antitrypsin) inhibited SARS-CoV-2 replication in therapeutically achievable concentrations.	Aprotinin inhibits sars-cov-2 replication	entailment
250	Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.	Aprotinin 1980s sars-cov-2 replication	not_entailment
251	Aprotinin Inhibits SARS-CoV-2 Replication.	Aprotinin (s sars-cov-2 replication	not_entailment
252	On the origin and continuing evolution of SARS-CoV-2.	Aprotinin 1970s sars-cov-2 replication	not_entailment
253	This observation confirms that homozygous L-SIGN does have a protective role in SARS-CoV infection.	Homozygous l-sign plays a protective role in sars coronavirus infection	entailment
254	Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.	Homozygous l-atpase plays a protective role in sars coronavirus infection	not_entailment
255	Cuomo warns US won't have enough hospital beds for coronavirus pandemic Published Mon, Mar 16 202011:27 AM EDTUpdated Mon, Mar 16 202012:18 PM EDT Berkeley Lovelace Jr.@BerkeleyJr ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email New York Gov.	The us doesnt have enough hospital beds for a bad coronavirus outbreak.	entailment
256	It’s understandable if you’re feeling worried about the coronavirus.	The usset have enough hospital beds for a bad coronavirus outbreak.	not_entailment
257	The state, for instance, has been stockpiling ventilators, which are critical for treating coronavirus patients who have a severe form of the illness.	The uswt have enough hospital beds for a bad coronavirus outbreak.	not_entailment
258	Designating one hospital in the system to work specifically with coronavirus cases may allow them to go even higher.	The usert have enough hospital beds for a bad coronavirus outbreak.	not_entailment
259	Dr. Anthony Cardillo said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients.	La doctor seeing 100 % success with hydroxychloroquine and zinc to treat covid-19	entailment
260	Dr. Anthony Cardillo said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients.	La doctor seeing 80 % success with hydroxychloroquine and zinc to treat covid-19	not_entailment
261	Dr. Anthony Cardillo said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients.	La doctor seeing 60 % success with hydroxychloroquine and zinc to treat covid-19	not_entailment
262	Dr. Anthony Cardillo said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients.	La doctor seeing 70 % success with hydroxychloroquine and zinc to treat covid-19	not_entailment
263	The race is on to find new drugs to treat COVID-19 patients and to develop a vaccine to prevent infection in the first place.	Repurposing existing drugs for covid-19 a more rapid alternative to a vaccine , say researchers	entailment
264	“While we're waiting for a vaccine, drugs currently being used to treat other illnesses can be investigated as treatments for COVID-19 – in other words repurposed,” said Dr Steve Alexander from the University of Nottingham.	Repurposing existing drugs for covid-19 a less rapid alternative to a vaccine, say researchers	not_entailment
265	In this report, we describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with remdesivir on a compassionate-use basis.	68 per cent of patients hospitalized for severe covid-19 , who were treated with compassionate-use remdesivir , showed clinical improvement	entailment
266	Remdesivir is an investigational agent that has not been licensed or approved anywhere globally, and it has not been demonstrated to be safe or effective for any use, including for the treatment of COVID-19.	68 per cent of patients hospitalized for severe covid-19, who were treated with compassionate-use remdesivir, without clinical improvement	not_entailment
267	Methods We used years of life lost (YLL) as the main outcome measure as applied to Switzerland as an exemplar.	Years of life lost due to the psychosocial consequences of covid19 mitigation strategies based on swiss data	entailment
268	Years of Life Lost Due to the Psychosocial Consequences of COVID-19 Mitigation Strategies Based on Swiss Data.	Years of life increases due to the psychosocial consequences of covid19 mitigation strategies based on swiss data	not_entailment
269	Years of life lost due to the psychosocial consequences of covid-19 mitigation strategies based on Swiss data.	Years of life remains due to the psychosocial consequences of covid19 mitigation strategies based on swiss data	not_entailment
270	Our projection suggests that the Swiss population will incur a substantial increase in mortality as a consequence of confinement-related psychosocial stress, which should be considered in forming public health responses to the pandemic.	Years of life occurred due to the psychosocial consequences of covid19 mitigation strategies based on swiss data	not_entailment
271	AstraZenecas is the first Phase 3 Covid-19 vaccine trial known to have been put on hold.	Astrazeneca covid-19 vaccine study is put on hold	entailment
272	(iStock) CLICK HERE FOR FULL CORONAVIRUS COVERAGE Last week, AstraZeneca announced its COVID-19 vaccine candidate entered the final testing stage in the U.S.	Astrazeneca covid-19 vaccine study is put on!	not_entailment
273	(iStock) CLICK HERE FOR FULL CORONAVIRUS COVERAGE Last week, AstraZeneca announced its COVID-19 vaccine candidate entered the final testing stage in the U.S.	"Astrazeneca covid-19 vaccine study is put on."""	not_entailment
274	(iStock) CLICK HERE FOR FULL CORONAVIRUS COVERAGE Last week, AstraZeneca announced its COVID-19 vaccine candidate entered the final testing stage in the U.S.	Astrazeneca covid-19 vaccine study is put on.	not_entailment
275	We are hopeful to contribute to flattening the COVID-19 curve, expanding on the promising early results weve seen in our clinical studies in devastating cancers to patients with coronavirus. This also comes after the FDA said this week it was looking to hit the gas pedal on new treatments for COVID-19.	Giuliani-promoted covid-19 therapy from celularity nabs fda speedy trial start	entailment
276	Giuliani-promoted COVID-19 therapy from Celularity nabs FDA speedy trial start.	Giuliani-free covid-19 therapy from celularity nabs fda speedy trial start	not_entailment
277	7: A schematic for AhR-upregulated mucins in the hypoxia of COVID-19 patients.	Mucus production stimulated by ifn-ahr signaling triggers hypoxia of covid-19	entailment
278	Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.	Mucus production stimulated by ifn-ahr signaling prevents hypoxia of covid-19	not_entailment
279	Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.	Mucus damage stimulated by ifn-ahr signaling triggers hypoxia of covid-19	not_entailment
280	Skip to main content 	Gilead has suspended access to remdesivir	entailment
281	For more information about remdesivir, please see the Emergency Use Authorization Fact Sheets available atwww.gilead.com/remdesivir.	Gilead has allowed access to remdesivir	not_entailment
282	For more information about remdesivir, please see the Emergency Use Authorization Fact Sheets available atwww.gilead.com/remdesivir.	Gilead has received access to remdesivir	not_entailment
283	For more information about remdesivir, please see the Emergency Use Authorization Fact Sheets available atwww.gilead.com/remdesivir.	Gilead has provided access to remdesivir	not_entailment
284	The scientists found that patients with severe COVID-19 displayed many of these hallmarks of extrafollicular B cell responses associated with lupus.	Immune cell activation in severe covid-19 resembles lupus .	entailment
285	The scientists found that patients with severe COVID-19 displayed many of these hallmarks of extrafollicular B cell responses associated with lupus.	Immune cell death in severe covid-19 resembles lupus.	not_entailment
286	Thursday, January 21st 2021, 7:46 AM EST By CNN Newswire New CDC director Dr. Rochelle Walensky The United States could face as many as 100,000 more COVID-19 deaths in less than a month, according to the US Centers for Disease Control and Prevention.	Cdc forecasts up to 100,000 more covid-19 deaths in the next few weeks.	entailment
287	By mid-May, all of the dozen forecasting models for COVID-19 deaths in the U.S. tracked by the CDC surpassed Trump's latest predictions.	Cdc forecasts up to 100,000 more covid-19 deaths in the next few decades.	not_entailment
288	A mass vaccination team will be set up in each of the nine Highway Patrol regions in the state, he said, and they will be able to administer up to 2,500 doses a day.	Cdc forecasts up to 100,000 more covid-19 deaths in the next few years.	not_entailment
289	READ MORE Everything You Should Know About the 2019 Coronavirus and COVID-19 Medically reviewed by Cameron White, MD, MPH Get the facts about the 2019 novel coronavirus (and COVID-19).	Cdc forecasts up to 100,000 more covid-19 deaths in the next few century.	not_entailment
290	The study provides insight into how limited testing and gaps in surveillance during the initial phase of the epidemic resulted in so many cases going undetected.	Gaps in early surveillance of coronavirus led to record-breaking us trajectory	entailment
291	It is important to maintain a comprehensive system for influenza surveillance for the following reasons: Influenza viruses are constantly changing (referred to as antigenic drift), and thus ongoing data collection and characterization of the viruses are required; Influenza viruses can also undergo an abrupt, major change (referred to as antigenic shift) that results in a virus that is different than currently circulating influenza viruses; surveillance of viruses will detect these changes and inform the public health response; Vaccines must be administered annually and are updated regularly based on surveillance findings; Treatment for influenza is guided by laboratory surveillance for antiviral resistance; and Influenza surveillance and targeted research studies are used to monitor the impact of influenza on different segments of the population (e.g.	Efforts in early surveillance of coronavirus led to record-breaking us trajectory	not_entailment
292	CONCLUSIONS : In our cohort of COVID-19 patients, immunosuppression was associated with a lower risk of moderate-severe ARDS.	Immunosuppression is associated with a lower risk of moderate to severe acute respiratory distress syndrome in covid-19 .	entailment
293	Immune-mediated lung injury and acute respiratory distress syndrome (ARDS) are associated with adverse outcomes in patients with COVID-19.	Immunosuppression is associated with a increased risk of moderate to severe acute respiratory distress syndrome in covid-19.	not_entailment
294	Immune-mediated lung injury and acute respiratory distress syndrome (ARDS) are associated with adverse outcomes in patients with COVID-19.	Immunosuppression is associated with a higher risk of moderate to severe acute respiratory distress syndrome in covid-19.	not_entailment
295	Keywords: COVID-19; acute respiratory distress syndrome; autoimmune diseases; immunosuppression; severe acute respiratory syndrome coronavirus 2.	Immunosuppression is associated with a high risk of moderate to severe acute respiratory distress syndrome in covid-19.	not_entailment
296	ACE2 is the critical cell surface receptor for SARS-CoV-2.	Human soluble ace2 improves the effect of remdesivir in sars-cov-2 infection	entailment
297	Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2.	Human soluble ace2 inhibits the effect of remdesivir in sars-cov-2 infection	not_entailment
298	Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2.	Human soluble ace2 blocked the effect of remdesivir in sars-cov-2 infection	not_entailment
299	Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2.	Human soluble ace2 reduces the effect of remdesivir in sars-cov-2 infection	not_entailment
300	A 5-day course of ivermectin resulted in an earlier clearance of the virus compared to placebo ( p = 0.005), thus indicating that early intervention with this agent may limit viral replication within the host.	A five day course of ivermectin for the treatment of covid-19 may reduce the duration of illness	entailment
301	A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness \- Open access February 2021 Sabeena Ahmed 	A five years course of ivermectin for the treatment of covid-19 may reduce the duration of illness	not_entailment
302	A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.	A five year course of ivermectin for the treatment of covid-19 may reduce the duration of illness	not_entailment
303	Some people taken by Covid-19 would likely have died from these diseases even in the five-month time frame.	A fivemonth course of ivermectin for the treatment of covid-19 may reduce the duration of illness	not_entailment
304	These observations led us to hypothesize that Brd4-bound enhancers might underlie sex differences in stem cell function and tumorigenicity in GBM.	Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma	entailment
305	10.1101/2021.01.28.428642 -- Posted: 2021-01-28 Modeling mutational effects on biochemical phenotypes using convolutional neural networks: application to SARS-CoV-2 Wang, B., Gamazon, E. R. 10.1101/2021.01.28.428521 -- Posted: 2021-01-28 Collection RSS 	Brd4-bound enhancers drive cell surface sex differences in glioblastoma	not_entailment
306	Effect of IL-6R trans-signaling inhibition on cytokine release from endothelial cells.	Il-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome	entailment
307	Effect of IL-6R trans-signaling inhibition on cytokine release from endothelial cells.	Il-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine development syndrome	not_entailment
308	Effect of IL-6R trans-signaling inhibition on cytokine release from endothelial cells.	Il-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine production syndrome	not_entailment
309	IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.	Il-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine differentiation syndrome	not_entailment
310	Fauci said he believes that while wearing a mask is not 100% effective, it is a valuable safeguard and shows respect for another person.	Fauci says he wears a mask to be a symbol of what 'you should be doing '	entailment
311	“I want to protect myself and protect others, and also because I want to make it a symbol for people to see that that’s the kind of thing you should be doing,” Fauci said.	Fauci says he wears a point to be a symbol of what 'you should be doing '	not_entailment
312	When asked by host Jim Sciutto if his wearing of a mask encouraged their use, Fauci acknowledged masks aren't 100% effective but are a valuable safeguard and part of respect for another person.	Fauci says he wears a license to be a symbol of what 'you should be doing '	not_entailment
313	“I want to protect myself and protect others, and also because I want to make it a symbol for people to see that that’s the kind of thing you should be doing,” Fauci said.	Fauci says he wears a question to be a symbol of what 'you should be doing '	not_entailment
314	2 Antibody responses kinetics to SARS-CoV-2 proteins.	Iga dominates the early neutralizing antibody response to sars-cov-2	entailment
315	IgA dominates the early neutralizing antibody response to SARS-CoV-2.	Iga dominates the full neutralizing antibody response to sars-cov-2	not_entailment
316	↵ D. Sterlin et al., IgA dominates the early neutralizing antibody response to SARS-CoV-2.	Iga dominates the enhanced neutralizing antibody response to sars-cov-2	not_entailment
317	IgA dominates the early neutralizing antibody response to SARS-CoV-2 	Iga dominates the effective neutralizing antibody response to sars-cov-2	not_entailment
318	Additionally, the data reviewed by the FDA demonstrated that the test is as accurate in the broader asymptomatic population as it is among people suspected to have COVID-19.	Fda authorizes first diagnostic test for screening of people without known or suspected covid-19 infection	entailment
319	FDA authorizes first diagnostic test for screening people without known or suspected COVID-19 infection 	Fda authorizes another diagnostic test for screening of people without known or suspected covid-19 infection	not_entailment
320	This is the second time trials for a Covid-19 vaccine trial have been paused over a safety concern.	Johnson & johnson pauses covid-19 vaccine trials due to sick subject	entailment
321	Johnson & Johnson pauses COVID-19 vaccine trials due to sick subject Share: October 13, 2020 	Johnson & johnson developed covid-19 vaccine trials due to sick subject	not_entailment
322	Therefore, it is likely that most nonparticipants were not in Wuhan at the time of the screening.	Asymptomatic cases may not be infectious , wuhan study indicates.	entailment
323	To err on safe side, it may be wise to presume that asymptomatic cases are also infectious.	Asymptomatic cases may also be infectious, wuhan study indicates.	not_entailment
324	A study from Wuhan, China, also found that asymptomatic patients may only be contagious for half as long as symptomatic patients.	Asymptomatic cases may only be infectious, wuhan study indicates.	not_entailment
325	We found that asymptomatic positive rates in different districts of Wuhan were correlated with the prevalence of previously confirmed cases.	Asymptomatic cases may still be infectious, wuhan study indicates.	not_entailment
326	ACE2 mRNA and protein expression are not found in goblet cells of the respiratory tract.	Robust ace2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ace inhibitors or angiotensin receptor blockers	entailment
327	First, we discover that ACE2 is robustly expressed in the motile cilia of the respiratory tract.	Robust ace2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is significantly increased by ace inhibitors or angiotensin receptor blockers	not_entailment
328	First, we discover that ACE2 is robustly expressed in the motile cilia of the respiratory tract.	Robust ace2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is greatly increased by ace inhibitors or angiotensin receptor blockers	not_entailment
329	In conclusion, we find that ACE2 protein expression is not only present in ciliated epithelial cells in the human respiratory tract, but that on a subcellular level, it is enriched in the motile cilia organelle of the ciliated epithelium.	Robust ace2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is further increased by ace inhibitors or angiotensin receptor blockers	not_entailment
330	Here we identify a consensus peripheral blood immune signature across 63 hospital-treated Covid-19 patients who were otherwise highly heterogeneous.	A consensus covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis	entailment
331	A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis.	A novel covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis	not_entailment
332	A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis.	A unique covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis	not_entailment
333	With this additional adjustment and using the same methodology and data from the original version of this report, the corrected estimate of the infection-fatality-ratio (IFR) is 0.94 (0.37, 2.9) percent.	The institute for disease modeling puts the cfr at 0.94 %	entailment
334	With this additional adjustment and using the same methodology and data from the original version of this report, the corrected estimate of the infection-fatality-ratio (IFR) is 0.94 (0.37, 2.9) percent.	The institute for disease transmission puts the cfr at 0.94 %	not_entailment
335	Health 79: 93-102.	The institute for disease surveillance puts the cfr at 0.94 %	not_entailment
336	Health 79: 93-102.	The institute for disease detection puts the cfr at 0.94 %	not_entailment
337	Share Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Songying Ouyang, Zheng-Li Shi Journal of Virology Sep 2020, 94 (20) e00902-20; DOI: 10.1128/JVI.00902-20 Share This Article: Copy Top Article ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS ACKNOWLEDGMENTS FOOTNOTES REFERENCES Figures & Data Info & Metrics PDF 	Evolutionary arms race between virus and host drives genetic diversity in bat sars related coronavirus spike genes	entailment
338	Share Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Song-Ying Ouyang, Zheng-Li Shi bioRxiv 2020.05.13.093658; doi: https://doi.org/10.1101/2020.05.13.093658 Share This Article: Copy Citation Tools Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Song-Ying Ouyang, Zheng-Li Shi bioRxiv 2020.05.13.093658; doi: https://doi.org/10.1101/2020.05.13.093658 	Evolutionary arms race between virus and coronavirus drives genetic diversity in bat sars related coronavirus spike genes	not_entailment
339	Share Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Song-Ying Ouyang, Zheng-Li Shi bioRxiv 2020.05.13.093658; doi: https://doi.org/10.1101/2020.05.13.093658 Share This Article: Copy Citation Tools Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Song-Ying Ouyang, Zheng-Li Shi bioRxiv 2020.05.13.093658; doi: https://doi.org/10.1101/2020.05.13.093658 	Evolutionary arms race between virus and viruses drives genetic diversity in bat sars related coronavirus spike genes	not_entailment
340	Share Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Song-Ying Ouyang, Zheng-Li Shi bioRxiv 2020.05.13.093658; doi: https://doi.org/10.1101/2020.05.13.093658 Share This Article: Copy Citation Tools Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Song-Ying Ouyang, Zheng-Li Shi bioRxiv 2020.05.13.093658; doi: https://doi.org/10.1101/2020.05.13.093658 	Evolutionary arms race between virus and virus drives genetic diversity in bat sars related coronavirus spike genes	not_entailment
341	At this time, symptomatic close contacts of a patient with confirmed COVID-19 should be further evaluated in consultation with public health authorities to review signs or symptoms and possible exposure on a case-by-case basis.	Active monitoring of persons exposed to patients with confirmed covid-19	entailment
342	However, no contacts were enumerated among those who were in the same airspace >2 hours after the patient with confirmed COVID-19.	Active monitoring of persons exposed to patients without confirmed covid-19	not_entailment
343	Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.	Convalescent plasma to treat covid-19	entailment
344	N	Unvalescent plasma to treat covid-19	not_entailment
345	The convalescent sera option for containing COVID-19.	Convalescent antibiotics to treat covid-19	not_entailment
346	N	Subvalescent plasma to treat covid-19	not_entailment
347	Photograph: John Locher/AP The man required hospitalisation and oxygen support the second time he caught coronavirus.	Man , 25 , catches coronavirus twice in first such us case	entailment
348	Photograph: John Locher/AP Press Association Tue 13 Oct 2020 01.24 EDT Researchers in the US have reported the country’s first confirmed case of coronavirus reinfection.	13, 25, catches coronavirus twice in first such us case	not_entailment
349	COVID-19 Coronavirus molecule, March 24, 2020.	2, 25, catches coronavirus twice in first such us case	not_entailment
350	COVID-19 Coronavirus molecule, March 24, 2020.	19, 25, catches coronavirus twice in first such us case	not_entailment
351	Fueled by a dark history of medical experimentation and unequal access to care, people in Black and Latino communities struggling with high Covid-19 rates are among those least likely to get vaccinated, health advocates say.	Black , hispanic communities struggle in covid-19 vaccine rollout across the u.s .	entailment
352	(Rivas, 1/28) The New York Times: Pregnant Women Get Conflicting Advice On Covid-19 Vaccines Pregnant women looking for guidance on Covid-19 vaccines are facing the kind of confusion that has dogged the pandemic from the start: The world’s leading public health organizations — the U.S. Centers for Disease Control and Prevention, and the World Health Organization — are offering contradictory advice.	2, hispanic communities struggle in covid-19 vaccine rollout across the u.s.	not_entailment
353	Fueled by a dark history of medical experimentation and unequal access to care, people in Black and Latino communities struggling with high Covid-19 rates are among those least likely to get vaccinated, health advocates say.	6, hispanic communities struggle in covid-19 vaccine rollout across the u.s.	not_entailment
354	Black, Hispanic communities struggle in COVID-19 vaccine rollout - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC : Digital Object Identifier : International Standard Serial Number : Doctor of Philosophy [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM : intensive care unit : Public Health England : general practitioner : Massachusetts : View this template : Discuss this template : Edit this template [Date Time]: 2020-06-17T00:38:15+10:00 : Department of Health and Social Care : United Kingdom	3, hispanic communities struggle in covid-19 vaccine rollout across the u.s.	not_entailment
355	But a small number of people with antibodies may still be able to carry and transmit COVID-19 according to the study.	Past covid-19 infection provides some immunity but people may still carry and transmit virus.	entailment
356	At this time, experts do not know how long someone is protected from getting sick again after recovering from COVID-19.	Past covid-19 infection provides some immunity but people cannot still carry and transmit virus.	not_entailment
357	Taken together, our results allow an explanation for differences in susceptibility towards IFNs and provide evidence that rational immune activation may be an effective future therapeutic strategy against SARS-CoV-2.	Systematic analysis of innate immune antagonism reveals vulnerabilities of sars-cov-2	entailment
358	Subsequent mechanistic studies revealed that SARS-CoV-2 proteins synergistically block innate immune induction at various levels.	Systematic analysis of cellular immune antagonism reveals vulnerabilities of sars-cov-2	not_entailment
359	Subsequent mechanistic studies revealed that SARS-CoV-2 proteins synergistically block innate immune induction at various levels.	Systematic analysis of adaptive immune antagonism reveals vulnerabilities of sars-cov-2	not_entailment
360	Systematic analysis of innate immune antagonism reveals vulnerabilities of SARS-CoV-2 	Systematic analysis of antiviral immune antagonism reveals vulnerabilities of sars-cov-2	not_entailment
361	An Update on Current Therapeutic Drugs Treating COVID-19.	Trial to promote recovery from covid-19 with ivermectin or endocrine therapy	entailment
362	This will be a randomized, open-label study to determine if bicalutamide or ivermectin improves the time to clinical improvement in patients with COVID-19 over historical controls.	Trial to no recovery from covid-19 with ivermectin or endocrine therapy	not_entailment
363	But they suggest that the candidate vaccines are broadly safe, and offer the first hints that vaccines can summon immune responses similar to those of people who have been infected with the virus.	Coronavirus vaccines leap through safety trials	entailment
364	During this phase, researchers will continue to evaluate vaccine dosing and immune response.	Coronavirus vaccines remain through safety trials	not_entailment
365	These trials can determine if the vaccine protects against the coronavirus, measuring what’s known as the efficacy rate.	Coronavirus vaccines work through safety trials	not_entailment
366	Delta Air Lines and Hawaiian Airlines have confirmed that a couple diagnosed with the coronavirus traveled on their flights in and around Hawaii earlier this month.	Couple diagnosed with coronavirus flew on delta , hawaiian airlines flights , carriers confirm	entailment
367	The constant change in coronavirus pandemic travel rules and restrictions makes staying on top of what international long-haul routes airlines are flying something of a game of cat and mouse.	Mice diagnosed with coronavirus flew on delta, hawaiian airlines flights, carriers confirm	not_entailment
368	11, 2019 Hassled every time in Oahu I have traveled many times with my Dogue De Bordeaux as a service dog and know all the rules and paperwork required....Hawaiian Airlines in Kona and Hilo and Seattle are wonderful...every time I have to go through Oahu even on inter’-island they are rude and try to tell me why my dog cannot go on the airplane....inter-island Oahu asked for my paperwork...the only thing they are allowed to ask me is does my dog provide a service and what that is...This time I got right in her face and all of a sudden my dog was allowed through without them needing anything...interesting.	Dogs diagnosed with coronavirus flew on delta, hawaiian airlines flights, carriers confirm	not_entailment
369	Given this; Hawaiian Airlines is lying when it says it is due to quarantine requirements that dogs and cats can't fly in-cabin.	Cats diagnosed with coronavirus flew on delta, hawaiian airlines flights, carriers confirm	not_entailment
370	The drug 's efficacy was above a threshold > of 80%, which is the criterion for a drug with high antiviral activity.	Latest data show above 80 % efficacy for favipiravir in covid-19 , say rdif and chemrar	entailment
371	According to the results of the first stage, Favipiravir demonstrated safety with no new or previously unreported side effects detected.	Latest data show only 80 % efficacy for favipiravir in covid-19, say rdif and chemrar	not_entailment
372	Production of Favipiravir anti-COVID-19 drug at Russian Direct Investment Fund and ChemRar joint venture in Khimki, Moscow Region (PRNewsfoto/RDIF) On 21 May 2020, the Ministry of Health of the Russian Federation approved the launch of the final stage, which will involve 330 patients compared to 60 during the initial stage, as well as additional research and medical centers.	Latest data show nearly 80 % efficacy for favipiravir in covid-19, say rdif and chemrar	not_entailment
373	Yee estimates commissioning roughly two million COVID-19 test kits in the next two months from Nanjing-based Vazyme Biotech, a Chinese producer of enzymes and antibodies.	Antibody test for covid-19 could help to control virus spread , says singapore medtech firm	entailment
374	Meanwhile, Singapore’s Ministry of Health issued a document released to all registered medical practitioners on April 3 stating, “There is currently no role for COVID-19 serology rapid test kits in the diagnosis of COVID-19 infections.” The Biolidics test checks the blood for antibodies and can identify who was previously infected and may have already developed immunity to the virus.	Antibody test for covid-19 cannot help to control virus spread, says singapore medtech firm	not_entailment
375	Seroprevalence was 3.66% using the POC test and 1.19% using venous blood test, with a significant difference between the two (p < 0.05).	Covid-19 seroprevalence among healthcare workers of a large covid hospital in rome reveals strengths and limits of two different serological tests.	entailment
376	Share COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests Giuseppe Vetrugno, Daniele Ignazio La Milia, Floriana D’Ambrosio, Marcello Di Pumpo, Roberta Pastorino, Stefania Boccia, Rosalba Ricci, Fabio De-Giorgio, Michela Cicconi, Federica Foti, Domenico Pascucci, Francesco Castrini, Elettra Carini, Andrea Cambieri, Maria Elena D’Alfonso, Gennaro Capalbo, Massimo Fantoni, Umberto Moscato, Domenico Staiti, Francesco Maria De Simone, Filippo Berloco, Maurizio Zega, Paola Cattani, Brunella Posteraro, Maurizio Sanguinetti, Patrizia Laurenti medRxiv 2021.01.08.21249445; doi: https://doi.org/10.1101/2021.01.08.21249445 Share This Article: Copy Citation Tools COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests Giuseppe Vetrugno, Daniele Ignazio La Milia, Floriana D’Ambrosio, Marcello Di Pumpo, Roberta Pastorino, Stefania Boccia, Rosalba Ricci, Fabio De-Giorgio, Michela Cicconi, Federica Foti, Domenico Pascucci, Francesco Castrini, Elettra Carini, Andrea Cambieri, Maria Elena D’Alfonso, Gennaro Capalbo, Massimo Fantoni, Umberto Moscato, Domenico Staiti, Francesco Maria De Simone, Filippo Berloco, Maurizio Zega, Paola Cattani, Brunella Posteraro, Maurizio Sanguinetti, Patrizia Laurenti medRxiv 2021.01.08.21249445; doi: https://doi.org/10.1101/2021.01.08.21249445 	Covid-19 seroprevalence among healthcare workers of a large covid hospital in rome reveals strengths and limits of three different serological tests.	not_entailment
377	Share COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests Giuseppe Vetrugno, Daniele Ignazio La Milia, Floriana D’Ambrosio, Marcello Di Pumpo, Roberta Pastorino, Stefania Boccia, Rosalba Ricci, Fabio De-Giorgio, Michela Cicconi, Federica Foti, Domenico Pascucci, Francesco Castrini, Elettra Carini, Andrea Cambieri, Maria Elena D’Alfonso, Gennaro Capalbo, Massimo Fantoni, Umberto Moscato, Domenico Staiti, Francesco Maria De Simone, Filippo Berloco, Maurizio Zega, Paola Cattani, Brunella Posteraro, Maurizio Sanguinetti, Patrizia Laurenti medRxiv 2021.01.08.21249445; doi: https://doi.org/10.1101/2021.01.08.21249445 Share This Article: Copy Citation Tools COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests Giuseppe Vetrugno, Daniele Ignazio La Milia, Floriana D’Ambrosio, Marcello Di Pumpo, Roberta Pastorino, Stefania Boccia, Rosalba Ricci, Fabio De-Giorgio, Michela Cicconi, Federica Foti, Domenico Pascucci, Francesco Castrini, Elettra Carini, Andrea Cambieri, Maria Elena D’Alfonso, Gennaro Capalbo, Massimo Fantoni, Umberto Moscato, Domenico Staiti, Francesco Maria De Simone, Filippo Berloco, Maurizio Zega, Paola Cattani, Brunella Posteraro, Maurizio Sanguinetti, Patrizia Laurenti medRxiv 2021.01.08.21249445; doi: https://doi.org/10.1101/2021.01.08.21249445 	Covid-19 seroprevalence among healthcare workers of a large covid hospital in rome reveals strengths and limits of all different serological tests.	not_entailment
378	L. Ye , Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor.	A neutralizing human antibody binds to the n-terminal domain of the spike protein of sars-cov-2	entailment
379	A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2.	A neutralizing mouse antibody binds to the n-terminal domain of the spike protein of sars-cov-2	not_entailment
380	There may be selective mutations in SARS-CoV-2, and it is necessary to avoid certain regions when designing primers and probes.	A novel point mutation in the n gene of sars-cov-2 may affect the detection of the virus by rt-qpcr.	entailment
381	A mutation in a reverse primer has been shown to affect the sensitivity of an RT-qPCR assay in use early in the pandemic10 and further mutations could lead to the occurrence of false negative results, particularly if the mutation occurs at the extreme 3′ end of the primers.	A third point mutation in the n gene of sars-cov-2 may affect the detection of the virus by rt-qpcr.	not_entailment
382	Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by a widely-used RT-PCR assay.	A major point mutation in the n gene of sars-cov-2 may affect the detection of the virus by rt-qpcr.	not_entailment
383	A study claims that gargling betadine substance for 15 to 30 seconds may destroy 99.9% of the SARS-CoV-2 in a human body.	99.9 % of sars-cov-2 gets destroyed after gargling betadine , claims study	entailment
384	Preliminary results show Betadine Gargle killed 99.9 percent of the virus within 15 seconds.	99.9 % of sars-cov-2 gets stable after gargling betadine, claims study	not_entailment
385	Preliminary results show Betadine Gargle killed 99.9 percent of the virus within 15 seconds.	99.9 % of sars-cov-2 gets effective after gargling betadine, claims study	not_entailment
386	Preliminary results show Betadine Gargle killed 99.9 percent of the virus within 15 seconds.	99.9 % of sars-cov-2 gets active after gargling betadine, claims study	not_entailment
387	An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.	Identification of sars-cov-2 vaccine epitopes predicted to induce long-term population-scale immunity	entailment
388	However, the disappearance of SARS-CoV infection prevented efficacy testing of these vaccines.	Identification of sars-cov-2 vaccine epitopes fails to induce long-term population-scale immunity	not_entailment
389	Progress and prospects on vaccine development against SARS- CoV-2.	Identification of sars-cov-2 vaccine epitopes failed to induce long-term population-scale immunity	not_entailment
390	1 Serial intervals of SARS-CoV-2 substantially shortened over time in mainland China.	Serial interval of sars-cov-2 was shortened over time by nonpharmaceutical interventions	entailment
391	Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions.	Serial interval of sars-cov-2 was increased over time by nonpharmaceutical interventions	not_entailment
392	Serial intervals of SARS-CoV-2 substantially… Fig.	Serial interval of sars-cov-2 was obtained over time by nonpharmaceutical interventions	not_entailment
393	Conclusions: Findings from this small group of cases suggest that SARS- CoV-2 virus does not exist in the vaginal fluids of severe COVID-19 patients.	Sars-cov-2 is not detectable in the vaginal fluid of women with severe covid-19 infection	entailment
394	This study aimed to evaluate whether or not SARS-CoV-2 is found in the vaginal fluid of women with COVID-19 illness.	Sars-cov-2 is also detectable in the vaginal fluid of women with severe covid-19 infection	not_entailment
395	This study aimed to evaluate whether or not SARS-CoV-2 is found in the vaginal fluid of women with COVID-19 illness.	Sars-cov-2 is only detectable in the vaginal fluid of women with severe covid-19 infection	not_entailment
396	This study aimed to evaluate whether or not SARS-CoV-2 is found in the vaginal fluid of women with COVID-19 illness.	Sars-cov-2 is still detectable in the vaginal fluid of women with severe covid-19 infection	not_entailment
397	Thus, SARS-CoV-2 infects monocytes and macrophages and induces a more sustained activation in macrophages without cytopathic effect.	Sars-cov-2 infects monocytes and macrophages , without cytopathic effect	entailment
398	SARS-CoV-2 infects monocytes and macrophages and stimulates cytokine release.	Sars-cov-2 infects monocytes and macrophages, cause cytopathic effect	not_entailment
399	SARS-CoV-2 infects monocytes and macrophages and stimulates cytokine release.	Sars-cov-2 infects monocytes and macrophages, an cytopathic effect	not_entailment
400	SARS-CoV-2 infects monocytes and macrophages and stimulates cytokine release.	Sars-cov-2 infects monocytes and macrophages, a cytopathic effect	not_entailment
